Stocktoria

Corvus Pharmaceuticals, Inc. CRVS

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2016-03-23 · LEI

Corvus Pharmaceuticals, Inc. statistics & valuation

Market cap$1.1B
P / B18.5×
Return on equity-25.0%
Return on capital-69.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2018201920202021202220232024202520252025
Operating margin (%)
2018201920202021202220232024202520252025
Return on equity (%)
-42.50% -65.60% -8.30% -44.50% -73.60% -69.90% -191.30% -25.00% 2018201920202021202220232024202520252025
Shares outstanding
29.3M 29.3M 29.5M 46.6M 46.6M 49.0M 67.9M 68.2M 74.5M 79.7M 2018201920202021202220232024202520252025
Net debt ($)
2018201920202021202220232024202520252025
Share buybacks ($)
2018201920202021202220232024202520252025
Return on assets (%)
-39.70% -55.80% -7.00% -39.50% -60.50% -59.30% -90.40% -21.50% 2018201920202021202220232024202520252025
Free cash flow margin (%)
2018201920202021202220232024202520252025
Debt / equity (×)
2018201920202021202220232024202520252025
EPS ($)
-$1.59 -$0.20 -$1.03 -$0.89 -$0.56 -$1.02 -$0.53 2018201920202021202220232024202520252025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2025FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Return on assets-21.5%——-90.4%-59.3%-60.5%-39.5%-7.0%-55.8%-39.7%
Return on equity-25.0%——-191.3%-69.9%-73.6%-44.5%-8.3%-65.6%-42.5%
Current ratio6.218.914.901.544.074.067.363.737.7616.45

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.